Amarin | Kortfristiga Skulder



Current Liabilities Ändra Datum
AbbVie USD 38.75B 4.31B 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amarin USD 201.55M 28.99M 2024-09
AstraZeneca USD 27.87B 1.94B 2024-12
DBV Technologies USD 30.91M 3.53M 2024-09
GlaxoSmithKline GBP 21.7B 238M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12



Amarin Kortfristiga Skulder - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.